PubMed=7989126; DOI=10.1002/ijc.2910590621
Bernhard H., Karbach J., Wolfel T., Busch P., Storkel S., Stockle M., Wolfel C., Seliger B., Huber C., Meyer zum Buschenfelde K.-H., Knuth A.
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Int. J. Cancer 59:837-842(1994)

PubMed=8864171; DOI=10.1111/j.1399-0039.1996.tb02601.x
Bernhard H., Jager E., Maeurer M.J., Meyer zum Buschenfelde K.-H., Knuth A.
Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
Tissue Antigens 48:22-31(1996)

PubMed=8900424; DOI=10.1002/(SICI)1097-0215(19961009)68:2<177::AID-IJC6>3.0.CO;2-V
Brouwenstijn N., Gaugler B., Kruse K.M., van der Spek C.W., Mulder A., Osanto S., van den Eynde B.J., Schrier P.I.
Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Int. J. Cancer 68:177-182(1996)

PubMed=9816317
Seliger B., Hohne A., Knuth A., Bernhard H., Ehring B., Tampe R., Huber C.
Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Clin. Cancer Res. 2:1427-1433(1996)

PubMed=10074909; DOI=10.1002/(SICI)1097-0215(19990315)80:6<799::AID-IJC1>3.0.CO;2-U
Dumas F., Gala J.-L., Berteau P., Brasseur F., Eschwege P., Paradis V., Lacour B., Philippe M., Loric S.
Molecular expression of PSMA mRNA and protein in primary renal tumors.
Int. J. Cancer 80:799-803(1999)

PubMed=11987130; DOI=10.1002/1615-9861(200205)2:5<561::AID-PROT561>3.0.CO;2-K
Lichtenfels R., Kellner R., Bukur J.H., Beck J., Brenner W., Ackermann A., Seliger B.
Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma.
Proteomics 2:561-570(2002)

CLPUB00420
Bukur J.H.
Characterization of T cell responses against human renal cell carcinoma and identification of HLA-G as a tumor-associated antigen and immune evasion mechanism of renal cell carcinoma.
Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany

PubMed=17200335; DOI=10.1158/1078-0432.CCR-06-0824
Seliger B., Fedorushchenko A., Brenner W., Ackermann A., Atkins D., Hanash S.M., Lichtenfels R.
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
Clin. Cancer Res. 13:27-37(2007)

PubMed=21595034; DOI=10.1002/pmic.201000486; PMCID=PMC3517181
Seliger B., Dressler S.P., Massa C., Recktenwald C.V., Altenberend F., Bukur J.H., Marincola F.M., Wang E., Stevanovic S., Lichtenfels R.
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.
Proteomics 11:2528-2541(2011)

PubMed=23696916; PMCID=PMC3657351
Stoehr C.G., Buettner-Herold M., Kamphausen E., Bertz S., Hartmann A., Seliger B.
Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.
Int. J. Clin. Exp. Pathol. 6:998-1008(2013)